Strides Pharma Science Limited has informed the Exchange regarding a press release dated December 28, 2021, titled "Strides receives DCGI approval under EUA to commercialize Molnupiravir, an oral medication for Covid-19".
Press Release Dec 28 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release Aug 06 2021
- Press Release Jun 28 2021
- Press Release Jun 14 2021
- Press Release May 27 2021
- Press Release Mar 19 2021
Later from Strides Pharma Science
- Press Release Jan 17 2022
- Press Release Jan 20 2022
- Press Release Feb 21 2022
- Press Release Mar 11 2022
- Extra Ordinary Meeting
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science